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Background: The exact prevalence of left ventricle non-compaction cardiomyopathy (LVNC) in south Asians is not
known and phenotypic CMR characteristics, clinical features, and outcomes of LVNC remain unknown for the SA
population.
Objective: To evaluate clinical characteristics, cardiac magnetic resonance imaging features, and outcomes of
patients with left ventricle non-compaction.
Methods: This was a retrospective study of 294 patients undergoing cardiac MRI (CMR) for evaluation of car
diomyopathy from 2011 to 2020. Patients were stratified based on the presence or absence of left ventricle noncompaction (LVNC). Clinical characteristics, CMR features, and outcomes were evaluated.
Results: Out of 294 patients, 18 patients had LVNC, with a prevalence of 6.1%. The mean age was 32 ± 13 years,
and the majority were males (78%). The mean EF by echo was 36 ± 14 and by CMR was 31 ± 16 and the mean
LV mass was 151 g. The mean LVEDV was 290 ± 154 and the mean LVESV was 211 ± 126. LGE was present in
33% of patients. The majority had uniform LV non-compaction (56%) followed by predominantly anterolateral
and apical involvement (28%). Mitral regurgitation was the most common valvular pathology (33%). On followup of 37 months, the majority experienced at least one all-cause MACE (69%), while 14% of patients experienced
mortality on follow-up. When compared with dilated cardiomyopathy patients without LVNC, the subjects were
younger (p = 0.002) and had higher EF by an echocardiogram (0.001) and a lower arrhythmia hospitalization (p
= 0.039). No difference was observed in overall MACE outcomes, mortality, and CMR features.
Conclusion: The prevalence of LVNC is low in the studied population. Patients with LVNC have younger age,
higher EF by echocardiogram, and lower arrhythmia hospitalization when compared with patients with dilated
cardiomyopathy without evidence of LV non-compaction. The presence of LVNC does not confer an increased
risk of MACE.

1. Introduction
Left Ventricle Non-Compaction Cardiomyopathy (LVNCC) is a type
of myocardial disease characterized by prominent myocardial trabec
ulae and recesses resulting in two distinct layers of the myocardium: the
compacted layer and the non-compacted layer. It arises due to the failure
of left ventricle (LV) maturation and compaction during intrauterine life
[1]. As per the position statement from the European Society of Cardi
ology, LVNCC has been labeled as an ‘unclassified’ type of cardiomy
opathy [2]. The clinical course can be complicated by heart failure,
thromboembolism, or arrhythmia [1].
Phenotypic presentation of LVNC can range from an extremely
thickened layer of non-compacted myocardium to the mere presence of

prominent trabeculae and recesses albeit a compacted myocardium [3].
Transthoracic echocardiography is the first tool to diagnose LVNC.
However, Cardiac Magnetic Resonance (CMR) imaging has emerged as a
strong tool to differentiate LVNCC from mere hyper-trabeculated LV
myocardium when an echocardiogram is inconclusive (Fig. 1). Various
criteria have evolved to diagnose LVNC by CMR. Peterson et al. defined
the end-diastole non-compacted to compacted myocardium ratio of
>2.3 to have good sensitivity, specificity, and negative predictive value
for
differentiating
pathological
non-compaction
from
hyper-trabeculation [4].
With an increase in the use of diagnostic cardiovascular imaging
modalities in the South-Asian (SA) belt, LVNC is being increasingly
diagnosed. The exact prevalence of LVNC in SA is not known and
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criteria [5]. This study has been registered with clinicaltrial.gov (UIN
NCT05281315).
3. Results
Out of 294 patients referred for CMR for evaluation of cardiomy
opathy, 18 patients were found to have LVNC, with a prevalence of
6.1%. The mean age was 32 ± 13 years, and males constituted most
subjects (78%). The most common presenting complaint was dyspnea
(95%), followed by palpitations (22%). Of note, none of the patients had
a history of stroke. The mean EF by echocardiogram was 36% (Table 1).
The mean EF by CMR was 31% and the mean LV mass was 151 g. The
majority (89%) had global hypokinesia. LGE was found in 33% of pa
tients (Table 2). The distribution of non-compaction was as shown in
Table 3. Mitral regurgitation (Table 3) was the most common valvular
pathology associated with LVNC (33%) (Fig. 2). Right ventricle
involvement was found in 2 patients (11%) (Fig. 3).
Follow-up was available for 16 patients (89%). On a mean follow-up
of 37 ± 31 months, mortality was observed in 2 patients (14%). A total
of 69% of subjects observed all-cause MACE on follow-up. The majority
had at least one hospitalization for CV reasons on follow-up. The most
common reason for hospitalization was heart failure (60%) followed by
arrhythmia (32%) (Table 4).
Patients with LV non-compaction were compared with patients with
dilated cardiomyopathy (DCM) without evidence of LV non-compaction.
Patients with LVNC were younger (p 0.002) and had higher EF by an
echocardiogram (p 0.001). No statistically significant difference was
observed for EF by CMR, presence of LGE, LV mass, and volumes. Pa
tients without LVNC had lower arrhythmia hospitalization but no dif
ference was observed in heart failure and total hospitalizations. Allcause MACE did not differ significantly between the two groups
(Table 5).

Fig. 1. Cardiac magnetic resonance imaging steady-state free precession stillframe 4-chamber view showing left ventricle non-compaction (arrow). LV left
ventricle, RV right ventricle.

phenotypic CMR characteristics, clinical features, and outcomes of
LVNC remain unknown for the SA population. This brought us to the
need of analyzing the CMR data of LVNC at our center.
2. Methodology
We retrospectively enrolled 294 patients referred for CMR from 2011
to 2020 for evaluation of cardiomyopathy. Of these, 51% were ischemic
cardiomyopathy, 26% were dilated cardiomyopathy, 25% were hyper
trophic cardiomyopathy, 13% were restrictive cardiomyopathy, and 6%
were arrhythmogenic right ventricle dysplasia. For final enrollment,
patients with intracardiac masses, pericardial diseases, and congenital
heart diseases were excluded from the study. Patients with evidence of
LV non-compaction were further analyzed for baseline characteristics,
CMR parameters, and outcomes. Characteristics of this group were
compared with 47 patients who had dilated cardiomyopathy without
evidence of LV non-compaction.
CMR was performed using a 1.5 T S Avanto Scanner with a breathhold steady-state free precision sequence performed for every patient.
Serial short and long-axis views were acquired using the following pa
rameters: a slice thickness of 7 mm, a distance factor of 25%, a field of
view of 34 cm, a matrix of 192 × 192, a flip angle of 80, a TR/TE of
58.74/1.12, and a bandwidth of 930 Hz/px. LGE images were acquired
after 8–10 min of gadolinium injection. Third-party software was used to
analyze all images (Media Q mass). Peterson criterion was used to di
agnose LVNC.
Data analysis was done using Statistical Package for Social Sciences
(SPSS) version 23.0.0 (IBM Corp. Released 2018). Results were pre
sented as mean ± standard deviation for continuous variables such as
age and LV volume and as a percentage for categorical variables.
Baseline and CMR characteristics were recorded for all patients. Patients
were followed up for any major adverse cardiovascular events (MACE)
which included all-cause mortality, heart failure hospitalization,
arrhythmia hospitalization, and cardiac implantable electronic device
implantation on follow-up. An independent t-test was used for contin
uous variables and a chi-square test was used for qualitative data. A twosided P < 0.05 was considered statistically significant for all tests.
Ethical approval was obtained from the ethical review committee of
the hospital. The work has been reported in line with the STROCSS

4. Discussion
LV non-compaction is a poorly understood entity. The exact preva
lence and prognostic significance of this entity remain largely unknown.
Recent years of CV imaging have witnessed an increase in the diagnostic
rate of LVNCC due to the increased use of CMR. There is a lack of large,
prospective, and conclusive data regarding the prognostic significance
and the clinical presentation. This entity carries a tendency of overdiagnosis and higher false-positive rates associated with various diag
nostic criteria and types of imaging modality used, as much as, it is not
Table 1
Baseline characteristics and echocardiographic features of patients with noncompaction on cardiac magnetic resonance imaging. SCD sudden cardiac
death, EF ejection fraction, LVEDD left ventricle end-diastolic diameter, LVESD
left ventricle end-systolic diameter, IVS interventricular septum.

2

Baseline characteristics

N = 18 (%)

Age (years)
Gender (Male)
Family history of cardiomyopathy
Family history of SCD
Dyspnea
Palpitation
Syncope/Presyncope
Diabetes Mellitus
Hypertension
History of stroke
Chronic Kidney Disease
Dyslipidemia
Echocardiographic characteristics
EF
LVEDD
LVESD
IVS thickness
Posterior wall thickness

32 ± 13 (Range 11–65)
14 (77.8)
1 (6)
1 (6)
17 (94.4)
4 (22)
3 (19)
0 (0)
1 (6)
0 (0)
0 (0)
0 (0)
36 ± 14
50 ± 11
39 ± 12
9±2
9±2
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Table 2
Cardiac Magnetic Resonance characteristics of patients with evidence of
non-compaction. EF ejection fraction, LVEDD left ventricle end-diastolic
diameter, LVESD left ventricle end-systolic diameter.
CMR characteristics

N = 18

LVEDV
LVESV
Stroke volume
EF (%)
LV mass
RV enlarged
RV systolic dysfunction
Global hypokinesia
Pericardial effusion
Myocardial edema
Late gadolinium enhancement
Thrombus by CMR
Non-compaction criteria fulfilled
Non-compaction criteria not fulfilled

290 ± 154
211 ± 126
79 ± 52
31 ± 16
151
2 (11)
3 (17)
16 (89)
2 (11)
1 (6)
6 (33)
1 (6)
11 (61)
7 (39)

Table 3
Distribution of non-compaction on Cardiac Magnetic Resonance imaging and
associated valvular pathologies. LV left ventricle, MR mitral regurgitations,
AR aortic regurgitation. M male, F female.
Preferential distribution of non-compaction

N (%)

Both ventricles
LV (uniform distribution)
Antero-lateral and apical
Apical
Valvular involvement
Mitral regurgitation
Aortic regurgitation

2 (11)
10 (56)
5 (28)
1 (6)
N (%)
6 (33)
1 (6)

Fig. 3. Cardiac magnetic resonance imaging steady-state free precision stillframe 4-chamber view showing left and right ventricle noncompaction (arrows).
Table 4
Outcomes of patients with LV non-compaction. CIED Cardiac implantable
electronic devices, CV Cardiovascular, MACE major adverse cardiovascular
events, LV left ventricle.
Outcomes on follow-up
Mean duration of follow-up (Months)
All-cause mortality on follow-up (%)
N = 14
MACE on follow-up (%)
N = 16
CIED on follow-up
Mean CV hospitalization
Total CV hospitalization
Total arrhythmia hospitalization (%)
Total heart failure hospitalization (%)
Lost-to-follow-up

37 months
2 (14)
11 (69)
2 (11)
1.56 ± 1.8
25
8 (32)
15 (60%)
4 (22)

South-Asian country. In our study from a South Asian tertiary care
center, the overall prevalence of LV non-compaction in patients referred
for CMR for evaluation of cardiomyopathy was 6.1%. According to the
results of a study by Ivanov et al., whereby in 700 patients referred for
CMR, LVNC had a prevalence of 39% by Petersen criteria (Also used in
our study) [7]. This indicates some geographical and racial differences
affecting the epidemiology of this entity. When compared with the LVNC
cohort from North Carolina by Ivanov et al., our patients had a younger
age of diagnosis and lower EF but comparable percentages of LGE and
valvular involvement [7].
We compared our group of LVNCs with DCM patients without evi
dence of non-compaction (Table 5 and Fig. 4). Our patients with noncompaction were strikingly younger (p = 0.002). Presence of noncompaction of any degree did not predict all-cause MACE (p = 0.346)
or heart failure hospitalization (p = 0.976). However, patients without

Fig. 2. Cardiac magnetic resonance imaging steady-state free precession stillframe 4-chamber view showing left ventricle non-compaction (yellow arrow),
mal-coaptation of the mitral valve (red arrow), and mitral regurgitation jet
(blue arrow). Left ventricle volumes are increased. (For interpretation of the
references to colour in this figure legend, the reader is referred to the Web
version of this article.)

possible to state the exact prevalence of LVNC.
A large meta-analysis of 59 studies of LVNC was done by Ross et al. In
this analysis, 26 cohorts were diagnosed using CMR, and Peterson
criteria was the most used one. The prevalence of LVNC by CMR was
14.79% (95% CI 8.85–21.85) versus 1.28% (95% CI 0.95–1.64) by
echocardiography [6]. However, this analysis did not include any
3
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M Ali et al. prospectively studied 19 patients who had MR in the setting
of LVNC with EF >45% by echocardiography. They found leaflet
retraction in all patients and zig-zag deformity and mal-coaptation in
57% of patients and ruptured chordae in 15% of patients [10].
CMR provides an exact estimation of volumes and additionally de
fines alternative etiology. It also provides prognostic information. This
study paves way for future CMR-based research in the country where
economic-driven constraints restrict the use of CMR, even when indi
cated. Prospective studies are needed at a larger scale to estimate the
overall outcomes of this disease entity in this part of the world.

Table 5
Comparison of patients with LV non-compaction with DCM patients with no
evidence of LV non-compaction. EF ejection fraction, LVESV left ventricle endsystolic volume, LVEDV left ventricle end-diastolic volume, LV left ventricle,
LGE late gadolinium enhancement.
Characteristics

Non-compaction of
any degree

DCM with no evidence
of non-compaction

Pvalue

Age (years)
EF by echocardiogram
EF by CMR
LVEDV by CMR
LVESV by CMR
LV SV by CMR
LV mass by CMR
Mean CV
hospitalization
Mean heart failure
hospitalization
Mean arrhythmia
hospitalization
All-cause MACE
LGE

29
44%
31%
276
209
67
144.8
1.17

41
24%
28%
229
168
61
144.7
1.85

0.002
0.001
0.47
0.06
0.09
0.266
0.996
0.113

0.78

0.79

0.976

0.33

0.94

0.039

6. Conclusion

67
33

79
51

0.346
0.269

The prevalence of LVNC is low in the studied population. Patients
with LVNC have younger age, higher EF by echocardiogram, and lower
arrhythmia hospitalization when compared with patients with dilated
cardiomyopathy without evidence of LV non-compaction. The presence
of LVNC does not confer an increased risk of MACE. Overall, the pre
dictors of all-cause in patients with LVNC likely remain to be the same as
for any cardiomyopathy (such as LGE and EF).

5. Study limitations
This was a single-centered study. We were limited by the number of
patients undergoing CMR due to cost constraints.

non-compaction had a significantly higher rate of arrhythmia hospital
izations (p = 0.039). Of note, EF by echocardiogram was higher in pa
tients with non-compaction (p = 0.001). However, this difference was
non-significant by CMR (p = 0.47). The possible cause of higher
arrhythmia hospitalization in patients without non-compaction could be
because of lower EF and a higher percentage of LGE in this group,
although not reaching the level of statistical significance. Hence, it is
very likely that predictors of outcomes in LVNC remain the same as for
any cardiomyopathy such as LGE, LV EF, and LV stroke volume [8].
The association of mitral regurgitation (MR) and LVNC in the pres
ence of normal EF is previously described in the literature [9,10]. His
tologically, the pathologies include myxomatous degeneration, mitral
valve (MV) leaflet sclerosis, and endocardial fibroelastosis. Phenotypic
presentations include poor leaflet coaptation with zig-zag deformity,
retracted leaflet, restricted movement of the leaflet, elongated chordae,
and papillary muscle involvement. In our study (Table 3), MR was the
most common valvular pathology associated with LVNC (6 out of 18,
33%). 3 out of 18 patients, had mal-coaptation of the mitral valve
resulting in moderate-severe MR (Video 1), one patient had immobile
posterior MV leaflet, and one patient had mitral valve prolapse (MVP).

Sources of funding
No funding acquired for this study.
Ethical approval
Ethical review committee of the Aga Khan University Hospital.
ERC number 2020-5594-14863.
Consent
Consent not applicable as no direct intervention or interaction with
human subjects.

Fig. 4. Comparison of patients with and without non-compaction. HF heart failure, CV cardiovascular, MACE major adverse cardiovascular event, LGE late gad
olinium enhancement, EF ejection fraction.
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